Other
Statins
0
Pipeline Programs↗
5
Active Trials↗
6
Companies Involved↗
Statins is an early-stage landscape with 0 programs across 6 companies. The most active players are Pfizer, Amarin Pharma Inc., Mario Negri Institute for Pharmacological Research.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
29
clinical trials
Completed20 · 69%
Not yet recruiting3 · 10%
Recruiting2 · 7%
Unknown status2 · 7%
Terminated2 · 7%
Clinical Trials
Trial Activity
29 trials
Statins and ARBs on Rheumatoid Activity
Recruiting·—·Phase 3·NCT03770702·45 enrolled
Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers
Not yet recruiting·SShaheed Benazir Bhutto University Sheringal Dir Upper·Phase 1·NCT07378293·100 enrolled
Statins to Prevent Cancer Associated Blood Clots
Not yet recruiting·—·Phase 4·NCT07303816·4,000 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)